ABSTRACT

INTRODUCTION Uterine fibroids or myomas are the most common pelvic tumors in women. The occurrence of these tumors in the reproductive age group is 25%–40% [1].

Uterine myomas are observed more frequently in pregnancy with an estimated incidence of 2%–4%, because many women are delaying childbearing to their late thirties or early forties, the time of greatest risk for myoma growth [2]. Uterine myomas are commonly encountered in women older than 30 years [1,2], and their growth is related to exposure to circulating estrogens levels. The  prevalence of leiomyomas among pregnant women ranges from 0.1% to 3.9% [3-7]. The effective rate of uterine myomas in pregnancy is unknown; however, they are associated with numerous pregnancy-related maternal and fetal complications, including spontaneous abortion, preterm labor, placental abruption, postpartum hemorrhage, and high rate of cesarean deliveries [8].